CD69 Modulates Sphingosine-1-Phosphate-Induced Migration of Skin Dendritic Cells  by Lamana, Amalia et al.
CD69 Modulates Sphingosine-1-Phosphate-Induced
Migration of Skin Dendritic Cells
Amalia Lamana1, Pilar Martin2, Hortensia de la Fuente2, Laura Martinez-Mun˜oz3, Aranzazu Cruz-Adalia2,
Marta Ramirez-Huesca2, Cristina Escribano4, Kathrin Gollmer5, Mario Mellado3, Jens V. Stein5,
Jose Luis Rodriguez-Fernandez4, Francisco Sanchez-Madrid1,2 and Gloria Martinez del Hoyo2
In this study, we have investigated the role of CD69, an early inducible leukocyte activation receptor, in murine
dendritic cell (DC) differentiation, maturation, and migration. Skin DCs and DC subsets present in mouse
lymphoid organs express CD69 in response to maturation stimuli. Using a contact sensitization model, we show
that skin DCs migrated more efficiently to draining lymph nodes (LNs) in the absence of CD69. This was
confirmed by subcutaneous transfer of CD69–/–DCs, which presented an increased migration to peripheral LNs.
Two-photon microscopy analysis showed that once DCs reached the LNs, CD69 deficiency did not alter DC
interstitial motility in the LNs. Chemotaxis to sphingosine-1-phosphate (S1P) was enhanced in CD69–/– DCs
compared with wild-type DCs. Accordingly, we detected a higher expression of S1P receptor type-1 (S1P1)
by CD69–/– DCs, whereas S1P3 expression levels were similar in wild-type and CD69–/– DCs. Moreover, in vivo
treatment with S1P analogs SEW2871 and FTY720 during skin sensitization reduced skin DC migration to
peripheral LNs. These results suggest that CD69 regulates S1P-induced skin DC migration by modulating S1P1
function. Together, our findings increase our knowledge on DC trafficking patterns in the skin, enabling the
development of new directed therapies using DCs for antigen (Ag) delivery.
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INTRODUCTION
The initiation of an immune response requires the accurate
positioning of dendritic cells (DCs) and T cells in the lymph
nodes (LNs). DCs are found in an immature stage in common
sites of pathogen entry, including skin and mucosal surfaces.
The prototype of immature DCs are Langerhans cells (LCs),
located in the skin together with dermal DCs (dDCs),
providing the first immunological barrier to the external
environment by their highly efficient antigen (Ag) capture
and processing machinery (Banchereau et al., 2000). This
property of cutaneous DCs has been exploited to improve
immune responses using different strategies (Romani et al.,
2010). DC maturation occurs after Ag encounter involving
the acquisition of the Ag presentation potential after
migration to the LNs through the afferent lymphatics.
Trafficking of DCs is controlled by different mechanisms
including chemoattractant receptors that allow them to
respond to a variety of ligands (Randolph et al., 2008).
The involvement of CCR7 (chemokine (C-C motif) receptor 7)
in the migration of mature DCs to the LNs has been well
established (Sallusto et al., 1998; Gunn et al., 1999; Sozzani
et al., 2000). Recently, it has been shown that DC migration
through interstitial spaces takes place independently of
integrins, being only necessary to overcome tissue barriers
like the endothelial layer (Woolf et al., 2007; Lammermann
et al., 2008). Sphingosine-1-phosphate (S1P) regulates lym-
phocyte trafficking and distribution within lymphoid organ
compartments. In particular, the S1P/S1P receptor type-1
(S1P1) axis controls lymphocyte egress from LNs (Matloubian
et al., 2004; Schwab and Cyster, 2007) and regulates T-cell
retention in peripheral tissues (Ledgerwood et al., 2008).
Several studies have illustrated the important role for S1P
during DC migration (Czeloth et al., 2005; Lan et al., 2005;
Idzko et al., 2006; Gollmann et al., 2008; Rathinasamy et al.,
2010); however, little is known about the precise step at
which this signal is required.
CD69, a member of the C-type lectin-like receptor family,
is transiently expressed in leukocytes following activation
(Cebrian et al., 1988; Testi et al., 1994; Sancho et al., 1999)
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and is detected persistently in leukocyte infiltrates in chronic
inflammatory diseases (Garcia-Monzon et al., 1990; Laffon
et al., 1991). Despite early data suggesting a proinflammatory
function for CD69 (Cebrian et al., 1988; Testi et al., 1989),
recent data, using different inflammatory models, point to an
immunoregulatory role by regulating effector T-cell responses
(Esplugues et al., 2003; Sancho et al., 2003; Cruz-Adalia
et al., 2010; Martin et al., 2010). Several studies suggest a
possible role for CD69 in the regulation of cell migration.
Constitutive expression of CD69 controls thymocyte export
(Feng et al., 2002; Nakayama et al., 2002). A subsequent
report showed that CD69 forms a complex with S1P1 on
T lymphocytes, which promotes the downregulation of S1P1
surface expression, inducing lymphocyte retention in the LNs
(Shiow et al., 2006; Bankovich et al., 2010). However, the
relationship between CD69 and S1P1 in other cell types
remains unclear.
Although the role of CD69 in T-cell trafficking has been
documented, there are no studies on the function of this
receptor on DCs. We have investigated the function of CD69 in
the regulation of skin DC migration to peripheral LNs. Skin
DC migration was significantly increased in CD69–/– mice.
Furthermore, mature CD69–/– DCs presented an enhanced
chemotactic response to S1P. The S1P analogs SEW2871 and
FTY720 interfered in vivowith DC migration and this correlated
with the increased expression of S1P1 in CD69–/–DCs without
modifying other S1P receptor expression. Together, our data
suggest that CD69 negatively regulates S1P1 expression on DCs
modulating skin DC migration toward LNs.
RESULTS
CD69 expression by skin and lymphoid organ DC
subpopulations
The expression of the activation receptor CD69 by the main
mouse skin-resident DC subsets was analyzed. Ex vivo-
isolated LCs and dDCs did not express CD69 under resting
conditions (Figure 1a). We next determine whether CD69
could be induced in skin DCs after maturation. LCs and
dDCs clearly upregulated CD69 expression levels after
overnight culture or the presence of tumor necrosis factor-a
(TNF-a) or lipopolysaccharide (LPS; Figure 1a). Analysis of
skin sections from wild-type and CD69–/– mice showed that
CD69 expression was not detected in skin from nonstimu-
lated mice (Figure 1b), suggesting that the upregulation of
CD69 is induced on skin DCs in response to maturation
stimuli or passive exit to the culture.
We analyzed the expression of CD69 on plasmacytoid
DCs (PDCs) and conventional DCs (cDCs) after Toll-like
receptor-induced maturation. We found that maturation
induced the expression of CD69 in fms-related tyrosine
kinase 3-ligand (Flt3L)-derived DCs (Figure 2a), and corre-
lated with the upregulation of major histocompatibility
complex-II (MHC-II) and CD86 (Figure 2a). Intravenous
injection of LPS and CpG induced CD69 expression on
splenic DCs (Figure 2b), together with the acquisition of the
mature phenotype (data not shown). In conclusion, matura-
tion stimuli promoted the upregulation of CD69 in the main
mouse DC subpopulations.
Differentiation and maturation of DC subpopulations in
CD69–/– mice
As CD69 increases during maturation, we next investigated
whether the DC differentiation and maturation were affected
in CD69–/– mice. The Flt3L-driven differentiation of plasma-
cytoid DCs and cDCs did not vary between wild-type and
CD69–/– mice, with similar proportions of each subpopula-
tion obtained (Figure 3a). Similarly, within each DC
subpopulation, there was no significant difference in the
expression of MHC-II, CD40, CD80, and CD86 between cells
from wild-type and CD69–/– mice, either before or after
maturation (Figure 3a).
We also analyzed whether CD69 deficiency affected
the presence of DC subpopulations in lymphoid organs. The
absolute number and the proportions of plasmacytoid DCs
and cDCs were the same in the spleens, LNs, and thymus
(not shown) of CD69–/– and wild-type mice. We compared
the response of wild-type and CD69–/– mice to intravenous
injection with LPS or CpG. Wild-type and CD69–/– splenic
cDCs and plasmacytoid DCs displayed a mature phenotype,
as indicated by the upregulation of MHC-II and CD86, and
there were no significant differences between the genotypes
in the expression of these molecules (Figure 3b).
In vivo migration of skin DCs to draining LNs in CD69–/–mice
We next investigated whether CD69 could be involved in
DC migration to peripheral LNs. To address this, we used
FITC skin sensitization assays in which migrated skin DCs
were fluorescently detected in draining LNs (Macatonia
et al., 1987; Anjuere et al., 1999). Higher numbers of
FITCþCD11cþ DCs were detected in skin-draining LNs
from CD69–/– mice compared with wild-type mice, after
24 hours of FITC painting (Figure 4a and e). At the three time
points analyzed, the number of FITCþCD11cþ DCs was
always higher in CD69–/– mice (Figure 4e). Analysis of
migrated FITCþCD11cþ DCs revealed that a minority of
these cells expressed CD207/Langerin (Figure 4b) or CD103
(Figure 4c), suggesting that FITCþ DCs mainly corresponded
to classical dDCs at 24 hours after skin sensitization (Figure
4b and c). In this regard, dDC migration peaks early at
24–48 hours, whereas LC migration is delayed until day 4 in
response to contact sensitizers (Kissenpfennig et al., 2005).
Wild-type FITCþCD11cþ cells expressed low levels of
CD69 in the LNs (Figure 4b). The enhanced numbers of
FITCþCD11cþ DCs detected in LNs from CD69–/– mice
was not because of differences in cell survival, as
FITCþCD11cþ cells did not express the apoptosis marker
caspase-3 (Figure 4d). Compared with resident LN-DCs,
immigrated-FITCþ DCs presented a mature phenotype, as
indicated by the expression levels of MHC-II, costimulatory
molecules, and chemokine receptors, with no differences in
the expression pattern of these markers between wild-type
and CD69–/–DCs (Supplementary Figure S1 online). In order
to determine whether the Ag dose could regulate
DC migration, we injected different concentrations of
ovalbumin-Alexa-488-conjugated protein subcutaneously in
wild-type and CD69–/– mice, and the presence of DCs that
uptake the fluorescent protein was analyzed in draining LNs.
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As shown in Supplementary Figure S2 online, our results
demonstrate that CD69/ DCs migrated more efficiently
than control DCs regardless of the amount of Ag used.
As the increased accumulation of DCs in the LNs of
CD69–/–mice might be a consequence of higher numbers of
skin DCs in these mice, we analyzed LCs and dDCs in
untreated wild-type and CD69–/–mice. Confocal microscopy
analysis of epidermal sheets revealed that there were no
differences in the morphology or distribution of MHC-IIþ
DCs in the epidermis of untreated wild-type and CD69–/–
mice (Figure 4f). We also quantified the DC passive exit from
skin explants after overnight culture by flow cytometry. The
proportion of wild-type and CD69–/– LCs and dDCs was
similar, demonstrating that the skin of CD69–/–mice contains
normal numbers of LCs and dDCs (Figure 4f).
Regarding the contribution of DCs to the differentiation of
T-helper cells in draining LNs after skin sensitization, we
assessed the T-cell cytokine expression profile in draining
LNs from wild-type and CD69–/– mice after FITC painting
assays. This analysis revealed that the percentage of IL-17þ
cells in these LNs was increased after skin sensitization in
CD69–/–mice compared with wild-type mice (Supplementary
Figure S3 online).
Two-photon microscopy analysis of CD69–/–DCs in draining LNs
To confirm the increased migratory potential of CD69–/–DCs,
we examined the migration of Flt3L-cDCs after transfer into
C57BL/6 host mice. cDCs were fluorescently labeled,
injected subcutaneously, and subsequently detected in
popliteal LNs. Consistent with the FITC skin painting results,
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Figure 1. Epidermal Langerhans cells (LCs) and dermal dendritic cells (DCs) express CD69 after maturation. (a) Histograms show the expression of CD69 by
epidermal LCs and dermal DCs, after ex vivo isolation (uncultured) and overnight culture in the absence or in the presence of tumor necrosis factor-a (TNF-a) or
lipopolysaccharide (LPS) maturation stimuli, in wild-type (WT) and CD69/ mice. Percentages of cells expressing CD69 are indicated. Expression profiles are shown
on a logarithmic scale along the x-axis. The results shown are from a representative experiment of three performed. (b) Skin sections from WT and CD69/
mice were stained with anti-CD69 (green), anti- major histocompatibility complex-II (MHC-II; red), and Hoechst (blue) for nuclear localization (scale bar¼ 20mm).
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CD69–/– DCs mice accounted for a significantly higher
proportion in LNs, further suggesting that they had migrated
more efficiently than wild-type DCs (Figure 5a).
To investigate the influence of CD69 in the DC intranodal
interstitial motility, we analyzed fluorescently labeled wild-
type and CD69–/– DCs in popliteal LNs by two-photon
microscopy. Regarding the distribution of DCs into the LNs,
both wild-type and CD69–/– DCs were mostly located
near high endothelial venules and the outer T-cell zone
(Supplementary Movies S1 and S2 online). The evaluation of
cellular motility parameters showed that wild-type and
CD69–/– DCs did not differ in velocity (Figure 5b; wild-type
mean±SEM: 5.220±0.1471, n¼94; CD69–/– DCs mean±
SEM: 5.521±0.1625, n¼158). The turning angle frequency
analysis showed a similar distribution in both genotypes
(Figure 5c) and, in accordance with previous data, DCs
showed a wide angle (Mempel et al., 2004; Cahalan and
Parker, 2005; Lammermann et al., 2008). Analysis of the
motility coefficient did not reveal significative differences in
wild-type and CD69–/– DCs (wild-type DCs: 5.87 mm2min–1;
CD69–/– DCs: 4.78mm2min–1; data not shown). These
observations indicate that once DCs have successfully
reached the LNs, CD69 does not appear to control the
intranodal DC motility.
Effect of S1P on CD69–/– DC migration
To investigate the mechanism underlying the increased
migration of CD69–/– DCs, we examined the potential role
of S1P, which regulates lymphocyte trafficking (Schwab and
Cyster, 2007; Ledgerwood et al., 2008) and DC migration
(Czeloth et al., 2005). We analyzed the chemotaxis to S1P
of mature CD69–/– cDCs. Over the S1P concentration range
determined to induce optimal migration, CD69–/– cDCs
migrated more efficiently to S1P than did wild-type cDCs
(Figure 6a). This increased response was specific to S1P, as
migration toward CXCL12 (chemokine (C-X-C motif) ligand
12) did not differ between wild-type and CD69–/– cDCs
(Figure 6b).
To investigate the influence of S1P during skin DC
migration, we used two S1P analogs: SEW2871, a specific
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Figure 2. Toll-like receptor (TLR)-induced maturation of plasmacytoid and conventional dendritic cell (pDC and cDC) subsets is associated with the induction
of CD69 surface expression. (a) Histograms show flow cytometry analysis of the surface expression of CD69 and CD86 on cDCs and pDCs derived
from fms-related tyrosine kinase 3-ligand (Flt3L)-driven bone marrow cultures, both before and after maturation with lipopolysaccharide (LPS) or CpG.
Expression profiles are shown on a logarithmic scale along the x-axis. Dotted lines correspond to the isotype control. The results shown are from a representative
experiment of five with similar results. (b) Effect of in vivo TLR-induced DC maturation on CD69 expression. Bar charts show expression of CD69 by
splenic pDCs and CD8aþ and CD8a cDCs at 15 hours after intravenous injection of LPS or CpG. The results shown are from a representative experiment
of three performed (five mice per group).
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agonist of S1P1, and FTY720, which binds four out of the
five S1P receptors. DC migration to the draining LNs was
significantly reduced after FTY720 and SEW2871 treatment,
both in wild-type and CD69–/– mice (Figure 6c), although
the extent of this reduction was higher after SEW2871 in
CD69–/– mice. These results suggest that S1P1-mediated
signaling could contribute to the increased CD69–/– DC
migration.
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As it has been shown that S1P modulates the migration of
DCs through S1P1 and S1P3 on mature DCs (Rathinasamy
et al., 2010), we analyzed the expression of S1P1 and S1P3 by
wild-type and CD69–/– mature DCs. We detected an almost
2-fold higher surface membrane expression of S1P1 in
CD69–/– DCs compared with wild-type DCs, whereas S1P3
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Figure 4. In vivo migration of skin dendritic cells (DCs) to draining lymph nodes (LNs) after FITC painting contact sensitization assay in CD69–/– mice.
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expression was similar in both cell types (Figure 6d).
However, both genotypes presented similar S1P1 and S1P3
mRNA expression levels (Figure 6e). We next analyzed the
expression of CD69 and S1P1 in wild-type DCs at different
time points after LPS-induced maturation. CD69 surface
expression was detected at 6 hours of LPS exposure in DCs,
and declined after 48 hours (Supplementary Figure S4A
online). Membrane expression of S1P1 was increased
at 48 hours after LPS stimulation, in parallel to the down-
regulation of CD69, in wild-type DCs (Supplementary Figure
S4B online). In addition, analysis of CD69 and S1P1 mRNA
expression in wild-type DCs at different time points
after maturation revealed that 6 hours after LPS treatment,
CD69 mRNA was reduced, as described for activated T cells
(Lopez-Cabrera et al., 1993), whereas S1P1 mRNA was
subsequently induced (Supplementary Figure S4C online).
These results support the fact that the absence of CD69
enhances membrane expression of S1P1 in DCs, thus
offering a possible explanation for the increased migration
of CD69–/– DCs.
DISCUSSION
The regulation of DC trafficking from peripheral tissues, such
as the skin, constitutes a crucial step for the initiation of
immune responses and inflammatory processes. We have
investigated the involvement of CD69 in the regulation of DC
migration, showing that this receptor can act as a retention
signal for DCs in peripheral tissues by a mechanism likely
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involving the modulation of S1P1 expression on DCs. CD69 is
not detected in mouse skin DCs under resting conditions, but
is upregulated after exposure to maturation stimuli in both
LCs and dDCs. CD69 constitutive expression had been
previously found in human LCs (Bieber et al., 1992). In
contrast, we show that in nonstimulatory conditions, CD69 is
absent in mouse skin DCs, but can be easily induced upon an
overnight culture period. Moreover, stimuli that induce DC
maturation also lead to the upregulation of CD69 in the main
mouse DC subsets. CD69–/– DCs displayed no apparent
abnormalities in their maturation, indicating that CD69 is not
necessary for the final differentiation of DCs. Furthermore,
normal proportions of DCs were observed in lymphoid
organs from CD69–/– mice, suggesting that under resting
conditions, DC differentiation and DC precursor recruitment
was not affected by the absence of CD69.
Our results show that in response to FITC skin sensitiza-
tion, DC migration is increased in the absence of CD69.
In this regard, according to our data on CD69 and
S1P1 sequential expression upon LPS-induced maturation,
the transitory induction of CD69 on early-activated DCs
would occur in peripheral tissues within the first hours after
inflammatory stimulation, blocking DC exit and thus increas-
ing the probability of Ag internalization. CD69 would be
subsequently downregulated, promoting S1P1 expression and
DC migration to the draining LNs. Accordingly, our FITC skin
sensitization experiments show that recently migrated FITCþ
DCs express very low CD69 levels in draining LNs. The
absence of CD69 did not alter the expression levels of the
chemokine receptors CCR7 and CXCR4 (chemokine (C-X-C
motif) receptor 4), indicating that the enhanced migration of
CD69–/–DCs was not probably because of the modulation of
surface expression of these receptors.
Several studies have demonstrated the contribution of S1P
during DC mobilization and migration (Czeloth et al., 2005;
Lan et al., 2005; Idzko et al., 2006; Maeda et al., 2007;
Gollmann et al., 2008; Rathinasamy et al., 2010), although
the precise step at which this molecule exerts its effect has
not been clearly established. S1P modulates the migration of
DCs through S1P1 and S1P3 on mature DCs (Czeloth et al.,
2005; Lan et al., 2005; Rathinasamy et al., 2010). We
detected a higher expression of S1P1 by CD69–/– DCs,
whereas S1P3 expression levels were similar in wild-type and
CD69–/– DCs. These data support that the absence of CD69
enhances the expression of S1P1, with no effect on other S1P
receptors. S1P1 and S1P3 mRNA expression levels were
similar in wild-type and CD69–/– mature DCs, suggesting a
post-transcriptional reciprocal regulatory mechanism invol-
ving direct protein–protein interactions as previously de-
scribed in T cells (Shiow et al., 2006; Bankovich et al., 2010).
Co-transfection experiments with these two receptors have
shown that when one cell expresses both proteins, the
molecule with higher expression prevents the surface
expression of the other molecule (Schwab and Cyster, 2007).
Two-photon microscopy analysis indicates that the
absence of CD69 does not affect the migratory speed of
DCs into the node. Furthermore, S1P1 does not seem to have
a relevant role in lymphocyte migration in the paracortex of
LNs (Halin et al., 2005). Thus, CD69–/– DCs should be
migrating intranodally in a similar way to wild-type DCs,
despite their higher sensitivity to S1P.
Many gaps remain in our knowledge of DC trafficking
patterns from peripheral tissues, which constitute a crucial
step in the initiation of many inflammatory disorders. In
particular, skin DC mobilization and migration is profoundly
impaired during early onset of psoriasis (Shaw et al., 2010).
The importance of skin DCs during the initial inflammatory
response in atopic dermatitis has also been highlighted
(Dubrac et al., 2010), as perturbations in skin barrier induce
the production of proinflammatory cytokines and migration
of skin DCs to LNs. On the other hand, targeting of Ags to
skin DCs enables the possibility to enhance vaccine efficacy.
A better understanding of these processes can be only
achieved by a complete knowledge of the DC receptors that
positively or negatively modulate the migration of DCs. In
this regard, it has been recently described that the MHC-II-
associated invariant chain CD74 negatively regulates DC
migration in vivo, through its association with myosin II
(Faure-Andre et al., 2008). These results provide, to our
knowledge, a previously unreported view of the function of
CD69 during DC migration from peripheral tissues toward
LNs, indicating that it operates as a negative regulator of
S1P1-induced chemotaxis by affecting the S1P1 receptor
expression. In summary, our data indicate that CD69 could
also be included as a selective regulator of the chemotaxis
mediated by S1P. It is feasible that CD69 may be part of a
larger group of membrane receptors that regulate the function
of different chemoattractants, by enhancing or inhibiting
relevant chemotactic responses.
MATERIALS AND METHODS
Mice
CD69-deficient mice were generated as described (Lauzurica et al.,
2000). CD69-deficient, 8-week-old mice backcrossed (for 410
generations) to the C57BL/6J genetic background and wild-type
C57BL/6 mice were bred at the School of Medicine of the
Universidad Autonoma (Madrid, Spain). The experimental proce-
dures were approved by the Committee for Research Ethics of the
Universidad Autonoma and conducted under the supervision of the
Universidad Autonoma Head of Animal Welfare and Health in
accordance with the Spanish and European guidelines.
Dendritic cells
Skin, splenic, and Flt3L-derived DCs were obtained as described
(Martinez del Hoyo et al., 2006). DCs were isolated by negative
selection using an Automacs magnetic cell sorter (Miltenyi Biotec,
Bergisch Gladbach, Germany) (Mittelbrunn et al., 2009). DC
maturation was induced by tumor necrosis factor-a (R&D Systems,
Minneapolis, MN), LPS (Sigma-Aldrich, St Louis, MO), or CpG-
ODN-1826 (InvivoGen, San Diego, CA).
FITC skin sensitization migration assay
The skin of mice was painted with 1% FITC (Sigma-Aldrich). LNs were
analyzed after 18, 24, and 48hours. Mice were supplied with drinking
water containing FTY720 or SEW2871 (Cayman Chemical, Ann Arbor,
MI) for 4 days before FITC skin sensitization. For analysis of cytokine
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expression, LNs were removed 4 days after FITC painting and
intracellular staining for IL-17 and IFN-g was performed as described.
Immunofluorescence assays
The preparation of skin samples for immunofluorescence assays is
described in detailed in Supplementary Materials and Methods
online.
In vitro transwell migration assays
Flt3L-cDCs were assessed in transwell plates (Corning, CoStar,
Cambridge, MA) in the presence of S1P (Sigma-Aldrich) and CXCL12
(R&D Systems) for 2 to 3 hours. The percentage of migrated cells was
determined by flow cytometry.
Two-photon laser scanning microscopy
The popliteal LNs of CD69–/– and wild-type mice were prepared
as described (Mempel et al., 2004). For a detailed description,
see Supplementary Materials and Methods online.
Western blot analysis
DC nuclear and cytosolic protein extracts were prepared with the
Proteo-Extract-Subcellular-Proteome Extraction Kit (Calbiochem,
San Diego, CA). Proteins were separated by 10% SDS-PAGE.
Quantification of the blots was performed using Multigauge software
from Fujifilm (Tokyo, Japan).
Quantitative RT-PCR
For a detailed description, see Supplementary Materials and
Methods online.
Flow cytometry
Cells were stained with the corresponding FITC, phycoerythrin, and
biotin-conjugated antibodies followed by streptavidin-PerCP
antibody from Becton-Dickinson (NJ) or eBioscience (San Diego,
CA). Cells were analyzed using a FACSCanto II flow cytometer
(Becton-Dickinson, Franklin Lakes, NJ).
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